Search research articles
Contact Us
Filters
Showing results (101-110 of 145) with videos related to
Page
of 15
Sort By:
Melanoma Research
|
November 14, 2023
Effectiveness, safety and utilization of cobimetinib and vemurafenib in patients with BRAF V600 mutant melanoma with and without cerebral metastasis under real-world conditions in Germany: the non-interventional study coveNIS
Katharina C Kähler, Dirk Debus, Gaston Schley, et al.
Cancers
|
January 10, 2026
Brentuximab Vedotin in Advanced-Stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-World Data from the German Cutaneous Lymphoma Network
Christoph Blazejak, Mathias Oymanns, René Stranzenbach, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
August 23, 2025
Low-dose total skin electron beam therapy in erythrodermic mycosis fungoides and Sézary syndrome: Results From the Prospective S-MISR Study
Khaled Elsayad, Christian Kandler, Jan Jakob Siats, et al.
Journal of Translational Medicine
|
November 7, 2015
Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma
Lisa Zimmer, Thomas K Eigentler, Felix Kiecker, et al.
Blood
|
May 22, 2023
Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study
Jan P Nicolay, Susanne Melchers, Jana D Albrecht, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 9, 2016
Mitoserate beim primären Melanom: Interobserver- und Intraobserver-Reproduzierbarkeit am HE-Schnitt und in der Immunhistologie
Claus Garbe, Thomas K Eigentler, Jürgen Bauer, et al.
The Lancet. Oncology
|
May 11, 2016
Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial
Ulrike Leiter, Rudolf Stadler, Cornelia Mauch, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 9, 2016
Mitotic rate in primary melanoma: interobserver and intraobserver reliability, analyzed using H&E sections and immunohistochemistry
Claus Garbe, Thomas K Eigentler, Jürgen Bauer, et al.
The Journal of Pathology. Clinical Research
|
January 16, 2026
Alcian blue-positive stromal phenotype in basal cell carcinoma is associated with progression on first-line hedgehog inhibitors
Viola K DeTemple, Rudolf Stadler, Sabine Bredemeier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 13, 2009
Prospective randomized multicenter adjuvant dermatologic cooperative oncology group trial of low-dose interferon alfa-2b with or without a modified high-dose interferon alfa-2b induction phase in patients with lymph node-negative melanoma
Axel Hauschild, Michael Weichenthal, Knuth Rass, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 145) with videos related to
Sort By:
Page
of 15
Melanoma Research
|
November 14, 2023
Effectiveness, safety and utilization of cobimetinib and vemurafenib in patients with BRAF V600 mutant melanoma with and without cerebral metastasis under real-world conditions in Germany: the non-interventional study coveNIS
Katharina C Kähler, Dirk Debus, Gaston Schley, et al.
Cancers
|
January 10, 2026
Brentuximab Vedotin in Advanced-Stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-World Data from the German Cutaneous Lymphoma Network
Christoph Blazejak, Mathias Oymanns, René Stranzenbach, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
August 23, 2025
Low-dose total skin electron beam therapy in erythrodermic mycosis fungoides and Sézary syndrome: Results From the Prospective S-MISR Study
Khaled Elsayad, Christian Kandler, Jan Jakob Siats, et al.
Journal of Translational Medicine
|
November 7, 2015
Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma
Lisa Zimmer, Thomas K Eigentler, Felix Kiecker, et al.
Blood
|
May 22, 2023
Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study
Jan P Nicolay, Susanne Melchers, Jana D Albrecht, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 9, 2016
Mitoserate beim primären Melanom: Interobserver- und Intraobserver-Reproduzierbarkeit am HE-Schnitt und in der Immunhistologie
Claus Garbe, Thomas K Eigentler, Jürgen Bauer, et al.
The Lancet. Oncology
|
May 11, 2016
Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial
Ulrike Leiter, Rudolf Stadler, Cornelia Mauch, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 9, 2016
Mitotic rate in primary melanoma: interobserver and intraobserver reliability, analyzed using H&E sections and immunohistochemistry
Claus Garbe, Thomas K Eigentler, Jürgen Bauer, et al.
The Journal of Pathology. Clinical Research
|
January 16, 2026
Alcian blue-positive stromal phenotype in basal cell carcinoma is associated with progression on first-line hedgehog inhibitors
Viola K DeTemple, Rudolf Stadler, Sabine Bredemeier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 13, 2009
Prospective randomized multicenter adjuvant dermatologic cooperative oncology group trial of low-dose interferon alfa-2b with or without a modified high-dose interferon alfa-2b induction phase in patients with lymph node-negative melanoma
Axel Hauschild, Michael Weichenthal, Knuth Rass, et al.
Page
of 15